Antibody‑drug conjugates (ADCs) are a rapidly-growing class of cancer therapy. Experts explain their science, clinical impact and future.
Antibody-drug conjugates: Advancing the search for more targeted cancer treatment
calendar_today
April 10, 2026
domain
gsk